OCA at 11:47, 13 December 2023

OCA — Wed, 13 Dec 2023 11:47:45 GMT

←Older revision		Revision as of 11:47, 13 December 2023
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry 8r8d is ON HOLD~~	+	==Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (symmetric dimer)==
-		+	<StructureSection load='8r8d' size='340' side='right'caption='[[8r8d]], [[Resolution\|resolution]] 2.60Å' scene=''>
-	~~Authors: Drulyte, I.~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[8r8d]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8R8D OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8R8D FirstGlance]. <br>
-	~~Description:~~ Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (symmetric dimer)	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution\|Resolution]] 2.6Å</td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	[[Category: Drulyte, I]]	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8r8d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8r8d OCA], [https://pdbe.org/8r8d PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8r8d RCSB], [https://www.ebi.ac.uk/pdbsum/8r8d PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8r8d ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/FA12_HUMAN FA12_HUMAN] Congenital factor XII deficiency;Hereditary angioedema type 3. Defects in F12 are the cause of factor XII deficiency (FA12D) [MIM:[https://omim.org/entry/234000 234000]; also known as Hageman factor deficiency. This trait is an asymptomatic anomaly of in vitro blood coagulation. Its diagnosis is based on finding a low plasma activity of the factor in coagulating assays. It is usually only accidentally discovered through pre-operative blood tests. F12 deficiency is divided into two categories, a cross-reacting material (CRM)-negative group (negative F12 antigen detection) and a CRM-positive group (positive F12 antigen detection).<ref>PMID:8528215</ref> <ref>PMID:2882793</ref> <ref>PMID:2510163</ref> <ref>PMID:8049433</ref> <ref>PMID:9354665</ref> <ref>PMID:10361128</ref> <ref>PMID:11776307</ref> <ref>PMID:15205584</ref> <ref>PMID:15617741</ref> Defects in F12 are the cause of hereditary angioedema type 3 (HAE3) [MIM:[https://omim.org/entry/610618 610618]; also known as estrogen-related HAE or hereditary angioneurotic edema with normal C1 inhibitor concentration and function. HAE is characterized by episodic local subcutaneous edema, and submucosal edema involving the upper respiratory and gastrointestinal tracts. HAE3 occurs exclusively in women and is precipitated or worsened by high estrogen levels (e.g. during pregnancy or treatment with oral contraceptives). It differs from HAE types 1 and 2 in that both concentration and function of C1 inhibitor are normal.<ref>PMID:16638441</ref> <ref>PMID:17186468</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/FA12_HUMAN FA12_HUMAN] Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then trypsin cleaves it to beta-factor XIIa. Alpha-factor XIIa activates factor XI to factor XIa.<ref>PMID:21304106</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Homo sapiens]]
		+	[[Category: Large Structures]]
		+	[[Category: Drulyte I]]

OCA: Protected "8r8d" [edit=sysop:move=sysop]

OCA — Wed, 06 Dec 2023 06:57:49 GMT

Protected "8r8d" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:57, 6 December 2023

OCA: New page: '''Unreleased structure''' The entry 8r8d is ON HOLD Authors: Drulyte, I. Description: Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (s...

OCA — Wed, 06 Dec 2023 06:57:48 GMT

New page: '''Unreleased structure''' The entry 8r8d is ON HOLD Authors: Drulyte, I. Description: Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (s...

New page

'''Unreleased structure'''

The entry 8r8d is ON HOLD

Authors: Drulyte, I.

Description: Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (symmetric dimer)
[[Category: Unreleased Structures]]
[[Category: Drulyte, I]]

8r8d - Revision history

OCA at 11:47, 13 December 2023

OCA: Protected "8r8d" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8r8d is ON HOLD Authors: Drulyte, I. Description: Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (s...